The effects of iron overload, insulin resistance and oxidative stress on metabolic disorders in patients with β- thalassemia major

被引:10
作者
Setoodeh, Soheila [1 ]
Khorsand, Marjan [2 ,3 ]
Takhshid, Mohammad Ali [2 ,3 ]
机构
[1] Shiraz Univ Med Sci, Sch Pharm, Shiraz, Iran
[2] Shiraz Univ Med Sci, Fac Paramed Sci, Lab Sci Dept, Shiraz, Iran
[3] Shiraz Univ Med Sci, Fac Paramed Sci, Diagnost Lab Sci & Technol Res Ctr, Meshkinfam St, Shiraz, Iran
关键词
beta- thalassemia major; Lipid profile; Oxidative stress; Insulin resistance; Iron overload; ISCHEMIA-MODIFIED ALBUMIN; ATHEROSCLEROSIS; MARKER;
D O I
10.1007/s40200-020-00560-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Serum lipids and glycemic dysregulation are the known characteristics of beta- thalassemia major (beta-TM). Here, we evaluated the association of these disorders with insulin resistance (IR), oxidative stress and serum ferritin values in patients with beta-TM. Methods This case-control study was performed in thalassemia unite of Darab Hospital (Darab, Fars province, Iran) from December 2016 to December 2017. Forty-eight patients with beta-TM and 33 healthy individuals were enrolled. Serum fasting blood sugar (FBS), insulin, total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), ischemia modified albumin (IMA), and ferritin were measured. The values of HOMA-IR, LDL: TG ratio, atherogenic index (AI), atherogenic index of plasma (AIP), and coronary risk index (CRI) were calculated. Results The level of serum ferritin, IMA, FBS, TG, AIP, LDL: TG ratio, and the prevalence of IR (HOMA-IR < 3.8) were significantly higher while TC, LDL-C, HDL-C, and AI were significantly lower in the patients compared to the control group. In patient with beta-TM, serum ferritin revealed to have a positive association with serum insulin, HOMA-IR, AI, and CRI levels while serum IMA showed positive association with TG and AIP and inverse association with hypocholesterolemia. HOMA-IR had positive correlation with HDL levels. Conclusions Oxidative stress and iron overload are predictors of serum glycemic and lipid dysregulation, suggesting possible beneficial effect of antioxidants and efficient iron chelating therapy in reducing the risk of metabolic disorders in beta- thalassemia.
引用
收藏
页码:767 / 774
页数:8
相关论文
共 38 条
  • [1] Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major
    Adly, Amira Abdel Moneam
    ElSherif, Nayera Hazaa Khalil
    Ismail, Eman Abdel Rahman
    Ibrahim, Yosra Abdelzaher
    Niazi, Gamal
    Elmetwally, Sara Hamed
    [J]. REDOX REPORT, 2017, 22 (06) : 430 - 438
  • [2] Al IO, 2019, J PEDIAT HEMATOL ONC, V41, pe463
  • [3] Amin A., 2005, IranJImmunol, V2, P220
  • [4] Arca V, 2012, PEDIAT THER, V2, P1
  • [5] Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes
    Asadi, Parvaneh
    Vessal, Mahmood
    Khorsand, Marjan
    Takhshid, Mohammad Ali
    [J]. JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2019, 18 (02) : 533 - 541
  • [6] Ischemia modified albumin: An oxidative stress marker in β-thalassemia major
    Awadallah, Samir M.
    Atoum, Manar F.
    Nimer, Nisreen A.
    Saleh, Suleiman A.
    [J]. CLINICA CHIMICA ACTA, 2012, 413 (9-10) : 907 - 910
  • [7] Ayyash H, 2018, INT J HEALTH SCI-IJH, V12, P18
  • [8] Serum Lipids in Turkish Patients with β-Thalassemia Major and β-Thalassemia Minor
    Balci, Yasemin Isik
    Unal, Sule
    Gumruk, Fatma
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (01) : 72 - 73
  • [9] Oxidative Status and Plasma Lipid Profile in β-Thalassemia Patients
    Boudrahem-Addour, Nassima
    Izem-Meziane, Malika
    Bouguerra, Khadidja
    Nadjem, Nassima
    Zidani, Nadia
    Belhani, Meriem
    Djerdjouri, Bahia
    [J]. HEMOGLOBIN, 2015, 39 (01) : 36 - 41
  • [10] Direct and indirect effects of false safety behaviors on cannabis use and related problems
    Buckner, Julia D.
    Zvolensky, Michael J.
    Businelle, Michael S.
    Gallagher, Matthew W.
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2018, 27 (01) : 29 - 34